Invesco Ltd. - NPS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Invesco Ltd. ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$88,695,000
+25.7%
2,479,581
-8.6%
0.03%
+21.4%
Q3 2014$70,533,000
-9.3%
2,712,806
+15.4%
0.03%
-9.7%
Q2 2014$77,724,000
+110.7%
2,351,726
+90.9%
0.03%
+106.7%
Q1 2014$36,880,000
+0.1%
1,232,185
+1.5%
0.02%0.0%
Q4 2013$36,860,000
+77.1%
1,214,126
+85.6%
0.02%
+66.7%
Q3 2013$20,809,000
+44.4%
654,155
-31.4%
0.01%
+28.6%
Q2 2013$14,414,000953,9560.01%
Other shareholders
NPS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 549,425$16,680,0006.89%
Opaleye Management Inc. 205,000$5,945,000,0004.67%
Rhenman & Partners Asset Management AB 240,000$7,286,0002.85%
SECTORAL ASSET MANAGEMENT INC 1,774,919$53,887,0002.32%
Eventide Asset Management 242,700$7,368,0002.27%
OAK RIDGE INVESTMENTS LLC 2,713,717$82,389,0002.16%
First Light Asset Management, LLC 68,245$2,072,0001.76%
Broadfin Capital, LLC 400,000$12,144,0001.60%
Cupps Capital Management, LLC 748,175$22,714,0001.54%
FCG ADVISORS, LLC 70,651$2,145,0001.45%
View complete list of NPS PHARMACEUTICALS INC shareholders